{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T06:10:22Z","timestamp":1729318222100,"version":"3.27.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"DOI":"10.7759\/cureus.71816","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T05:37:44Z","timestamp":1729316264000},"source":"Crossref","is-referenced-by-count":0,"title":["Refractory Hypercalcemia of Malignancy in Squamous Cell Carcinoma of the Buccal Mucosa With Skeletal Muscle Metastasis"],"prefix":"10.7759","author":[{"given":"Sai Krishna","family":"Reddy Bana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagannath S","family":"Dhadwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumar","family":"Roushan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhanjan","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandan","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.2890070202","article-title":"The incidence of hypercalcemia in squamous cell carcinoma of the head and neck","volume":"7","author":"Dorman EB","year":"1984","unstructured":"Dorman EB, Yang H, Vaughan CW, Hong WK, Strong MS. The incidence of hypercalcemia in squamous cell carcinoma of the head and neck. Head Neck Surg. 1984, 7:95-8. 10.1002\/hed.2890070202","journal-title":"Head Neck Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.08.002","article-title":"Treatment of hypercalcemia of malignancy","volume":"50","author":"Chakhtoura M","year":"2021","unstructured":"Chakhtoura M, El-Hajj Fuleihan G. Treatment of hypercalcemia of malignancy. Endocrinol Metab Clin North Am. 2021, 50:781-92. 10.1016\/j.ecl.2021.08.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.7941","article-title":"Endocrine Society hypercalcemia of malignancy guidelines","volume":"9","author":"Dickens LT","year":"2023","unstructured":"Dickens LT, Derman B, Alexander JT. Endocrine Society hypercalcemia of malignancy guidelines. JAMA Oncol. 2023, 9:430-1. 10.1001\/jamaoncol.2022.7941","journal-title":"JAMA Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/00016480410024613","article-title":"Distant muscular (gluteus maximus muscle) metastasis from laryngeal squamous cell carcinoma","volume":"125","author":"Marioni G","year":"2005","unstructured":"Marioni G, Blandamura S, Calgaro N, Ferraro SM, Stramare R, Staffieri A, De Filippis C. Distant muscular (gluteus maximus muscle) metastasis from laryngeal squamous cell carcinoma. Acta Otolaryngol. 2005, 125:678-82. 10.1080\/00016480410024613","journal-title":"Acta Otolaryngol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/BF01496721","article-title":"Hypocalcemia in malignant diseases [Article in German]","volume":"61","author":"Heidbreder E","year":"1983","unstructured":"Heidbreder E, Schafferhans K, Heidland A. Hypocalcemia in malignant diseases [Article in German]. Klin Wochenschr. 1983, 61:773-83. 10.1007\/BF01496721","journal-title":"Klin Wochenschr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/bs.vh.2022.03.002","article-title":"Parathyroid hormone-related protein (PTHrP) and malignancy","volume":"120","author":"Grunbaum A","year":"2022","unstructured":"Grunbaum A, Kremer R. Parathyroid hormone-related protein (PTHrP) and malignancy. Vitam Horm. 2022, 120:133-77. 10.1016\/bs.vh.2022.03.002","journal-title":"Vitam Horm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2814","article-title":"Parathyroid hormone-related protein localization in breast cancers predict improved prognosis","volume":"66","author":"Henderson MA","year":"2006","unstructured":"Henderson MA, Danks JA, Slavin JL, et al.. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res. 2006, 66:2250-6. 10.1158\/0008-5472.CAN-05-2814","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s007840100123","article-title":"Hypercalcemia in patients with oral squamous cell carcinoma","volume":"5","author":"Iwase M","year":"2001","unstructured":"Iwase M, Kurachi Y, Kakuta S, Sakamaki H, Nakamura-Mitsuhashi M, Nagumo M. Hypercalcemia in patients with oral squamous cell carcinoma. Clin Oral Investig. 2001, 5:194-8. 10.1007\/s007840100123","journal-title":"Clin Oral Investig"},{"key":"ref9","article-title":"Malignancy-related hypercalcemia","author":"Vakiti A","year":"2024","unstructured":"Vakiti A, Anastasopoulou C, Mewawalla P. Malignancy-related hypercalcemia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref10","article-title":"Clinical manifestations of cancer-related hypercalcemia","volume":"17","author":"Bajorunas DR","year":"1990","unstructured":"Bajorunas DR. Clinical manifestations of cancer-related hypercalcemia. Semin Oncol. 1990, 17:16-25.","journal-title":"Semin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2010.11.028","article-title":"Cancer-associated hypercalcaemia in squamous-cell malignancies: a survival and prognostic factor analysis","volume":"40","author":"Le Tinier F","year":"2011","unstructured":"Le Tinier F, Vanhuyse M, Penel N, Dewas S, El-Bedoui S, Adenis A. Cancer-associated hypercalcaemia in squamous-cell malignancies: a survival and prognostic factor analysis. Int J Oral Maxillofac Surg. 2011, 40:938-42. 10.1016\/j.ijom.2010.11.028","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF02553290","article-title":"Salmon calcitonin in the acute management of hypercalcemia","volume":"46","author":"Wisneski LA","year":"1990","unstructured":"Wisneski LA. Salmon calcitonin in the acute management of hypercalcemia. Calcif Tissue Int. 1990, 46:S26-30. 10.1007\/BF02553290","journal-title":"Calcif Tissue Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj105","article-title":"Management of the adverse effects associated with intravenous bisphosphonates","volume":"17","author":"Tanvetyanon T","year":"2006","unstructured":"Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol. 2006, 17:897-907. 10.1093\/annonc\/mdj105","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1001","article-title":"Denosumab for treatment of hypercalcemia of malignancy","volume":"99","author":"Hu MI","year":"2014","unstructured":"Hu MI, Glezerman IG, Leboulleux S, et al.. Denosumab for treatment of hypercalcemia of malignancy. J Clin Endocrinol Metab. 2014, 99:3144-52. 10.1210\/jc.2014-1001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111353","article-title":"Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia","volume":"73","author":"Warrell RP Jr","year":"1984","unstructured":"Warrell RP Jr, Bockman RS, Coonley CJ, Isaacs M, Staszewski H. Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia. J Clin Invest. 1984, 73:1487-90. 10.1172\/JCI111353","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-17-0118","article-title":"Hypercalcemia of malignancy treated with cinacalcet","volume":"2017","author":"Asonitis N","year":"2017","unstructured":"Asonitis N, Kassi E, Kokkinos M, Giovanopoulos I, Petychaki F, Gogas H. Hypercalcemia of malignancy treated with cinacalcet. Endocrinol Diabetes Metab Case Rep. 2017, 2017:10.1530\/EDM-17-0118","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(97)90044-5","article-title":"Correction of hypercalcemia and hypophosphatemia by hemodialysis using a conventional, calcium-containing dialysis solution enriched with phosphorus","volume":"29","author":"Leehey DJ","year":"1997","unstructured":"Leehey DJ, Ing TS. Correction of hypercalcemia and hypophosphatemia by hemodialysis using a conventional, calcium-containing dialysis solution enriched with phosphorus. Am J Kidney Dis. 1997, 29:288-90. 10.1016\/s0272-6386(97)90044-5","journal-title":"Am J Kidney Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz278","article-title":"Calcitriol elevation is associated with a higher risk of refractory hypercalcemia of malignancy in solid tumors","volume":"105","author":"Chukir T","year":"2020","unstructured":"Chukir T, Liu Y, Hoffman K, Bilezikian JP, Farooki A. Calcitriol elevation is associated with a higher risk of refractory hypercalcemia of malignancy in solid tumors. J Clin Endocrinol Metab. 2020, 105:e1115-23. 10.1210\/clinem\/dgz278","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac150.309","article-title":"LBSAT142 discovery and characterization of a potent and orally bioavailable parathyroid hormone receptor type-1 (PTHR1) antagonist for the treatment of hypercalcemia","volume":"6","author":"Rico-Bautista E","year":"2022","unstructured":"Rico-Bautista E, Pontillo J, Wang S, et al.. LBSAT142 discovery and characterization of a potent and orally bioavailable parathyroid hormone receptor type-1 (PTHR1) antagonist for the treatment of hypercalcemia. J Endocr Soc. 2022, 6:A151-2. 10.1210\/jendso\/bvac150.309","journal-title":"J Endocr Soc"},{"key":"ref20","article-title":"Imaging of the skeletal muscle metastases","volume":"16","author":"Arpaci T","year":"2012","unstructured":"Arpaci T, Ugurluer G, Akbas T, Arpaci RB, Serin M. Imaging of the skeletal muscle metastases. Eur Rev Med Pharmacol Sci. 2012, 16:2057-63.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/292927-refractory-hypercalcemia-of-malignancy-in-squamous-cell-carcinoma-of-the-buccal-mucosa-with-skeletal-muscle-metastasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T05:37:45Z","timestamp":1729316265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/292927-refractory-hypercalcemia-of-malignancy-in-squamous-cell-carcinoma-of-the-buccal-mucosa-with-skeletal-muscle-metastasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.71816","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}